http://www.kalvista.com
KalVista Pharmaceuticals, Inc. Company Intro
Copyright © 2020 | All rights reserved.
Industry
Healthcare
KalVista Pharmaceuticals, Inc. Headquaters
55 Cambridge Parkway
Cambridge,02142
United States
KalVista Pharmaceuticals, Inc. Share price
20 Oct 2020 01:55 GMT
$16.51
0.3 (1.85 %)
KalVista Pharmaceuticals, Inc. Market cap
$275.598 M
WMC RANKING
2020
KalVista Pharmaceuticals, Inc. # 144
BiotechnologyLatest KalVista Pharmaceuticals, Inc. News
19 Oct 2020
Liquidia Technologies (LQDA) Gets a Buy Rating from Needham
The company's shares closed last Monday at $3.47, close to its 52-week low of ... Pharmaceuticals, Collegium Pharmaceutical, and KalVista Pharmaceuticals.
19 Oct 2020
Liquidia Technologies (LQDA) Gets a Buy Rating from Needham
The company's shares closed last Monday at $3.47, close to its 52-week low of ... Pharmaceuticals, Collegium Pharmaceutical, and KalVista Pharmaceuticals.
19 Oct 2020
Liquidia Technologies (LQDA) Gets a Buy Rating from Needham
The company's shares closed last Monday at $3.47, close to its 52-week low of ... Pharmaceuticals, Collegium Pharmaceutical, and KalVista Pharmaceuticals.
WMC Market Score
WMC Market to Revenue Score
| Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score | |
| KalVista Pharmaceuticals, Inc. | 0.25 | 0.27 | 0.73 | 0 | 0 | 0 | 0.75 |
| Alexion Pharmaceuticals, Inc. | 100 | 13.14 | 100 | 19 | 0 | 0 | 99.09 |
| Vertex Pharmaceuticals Incorporated | 97.58 | 100 | 3.66 | 30 | 0 | 0 | 100 |
| 3SBio Inc. | 96.05 | 0 | 0 | 4 | 0 | 0 | 3.03 |
| Incyte Corporation | 40.27 | 14.26 | 7.07 | 100 | 0 | 0 | 91.10 |
KalVista Pharmaceuticals, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| KalVista Pharmaceuticals, Inc. | $14,105 | $50,877 | $-25,723 | $275.598M | 144 |
| Alexion Pharmaceuticals, Inc. | $5,536,800 | $2,523,000 | $846,100 | $26.687B | 1 |
| Vertex Pharmaceuticals Incorporated | $5,402,685 | $2,634,428 | $2,080,775 | $57.436B | 2 |
| 3SBio Inc. | ¥5,318,091 | ¥3,085,221 | ¥973,717 | ¥19.572B | 3 |
| Incyte Corporation | $2,229,409 | $1,622,822 | $446,906 | $19.193B | 4 |